טוען...
Efficacy of Secukinumab for Plaque Psoriasis in a Patient on Hemodialysis
Secukinumab is effective to treat plaque psoriasis. However, the safety and efficiency of secukinumab have not been clarified in patients on hemodialysis. We report a 60-year-old Japanese woman. Plaque psoriasis was diagnosed at the age of 25 years and hemodialysis was started at the age of 39 years...
שמור ב:
| הוצא לאור ב: | CEN Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Singapore
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6990267/ https://ncbi.nlm.nih.gov/pubmed/31654299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-019-00426-z |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|